152 related articles for article (PubMed ID: 2197455)
1. Tris(2-chloroethyl) phosphate.
IARC Monogr Eval Carcinog Risks Hum; 1990; 48():109-20. PubMed ID: 2197455
[No Abstract] [Full Text] [Related]
2. Nephrotoxicity of the flame retardant, tris(2,3-dibromopropyl) phosphate, and its metabolites.
Elliott WC; Lynn RK; Houghton DC; Kennish JM; Bennett WM
Toxicol Appl Pharmacol; 1982 Jan; 62(1):179-82. PubMed ID: 7064152
[No Abstract] [Full Text] [Related]
3. [Effect of oral administration of tris(2-chloroethyl) phosphate to pregnant rats on prenatal and postnatal development].
Kawashima K; Tanaka S; Nakaura S; Nagao S; Endo T; Onoda K; Takanaka A; Omori Y
Eisei Shikenjo Hokoku; 1983; (101):55-61. PubMed ID: 6675772
[No Abstract] [Full Text] [Related]
4. Species differences in kidney toxicity and metabolic activation of tris(2,3-dibromopropyl)phosphate.
Søderlund EJ; Nelson SD; von Bahr C; Dybing E
Fundam Appl Toxicol; 1982; 2(4):187-94. PubMed ID: 7185616
[No Abstract] [Full Text] [Related]
5. A new mutagenic and genotoxic response of the flame retardant tris(2,3-dibromopropyl)phosphate. Activation by singlet oxygen.
McCoy E; Hyman J; Rosenkranz HS
Mutat Res; 1980 Mar; 77(3):209-14. PubMed ID: 6991918
[TBL] [Abstract][Full Text] [Related]
6. Tris(2-chloroethyl) phosphate.
IARC Monogr Eval Carcinog Risks Hum; 1999; 71 Pt 3(PT 3):1543-8. PubMed ID: 10476442
[No Abstract] [Full Text] [Related]
7. Rat teratology study of orally administered tris-(2,3-dibromopropyl) phosphate.
Seabaugh VM; Collins TF; Hoheisel CA; Bierbower GW; McLaughlin J
Food Cosmet Toxicol; 1981 Feb; 19(1):67-72. PubMed ID: 7262733
[No Abstract] [Full Text] [Related]
8. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate.
Søderlund EJ; Dybing E; Holme JA; Hongslo JK; Rivedal E; Sanner T; Nelson SD
Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):20-9. PubMed ID: 3883695
[TBL] [Abstract][Full Text] [Related]
9. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites.
Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E
Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285
[TBL] [Abstract][Full Text] [Related]
10. Effects of tris(1-chloro-2-propyl)phosphate and tris(2-chloroethyl)phosphate on cell viability and morphological changes in peripheral blood mononuclear cells (in vitro study).
Mokra K; Bukowski K; Woźniak K
Hum Exp Toxicol; 2018 Dec; 37(12):1336-1345. PubMed ID: 29945461
[TBL] [Abstract][Full Text] [Related]
11. DNA damage and methylation induced by organophosphate flame retardants: Tris(2-chloroethyl) phosphate and tris(1-chloro-2-propyl) phosphate in human peripheral blood mononuclear cells.
Bukowski K; Wysokinski D; Mokra K; Wozniak K
Hum Exp Toxicol; 2019 Jun; 38(6):724-733. PubMed ID: 30935230
[TBL] [Abstract][Full Text] [Related]
12. Toxicity profiling of flame retardants in zebrafish embryos using a battery of assays for developmental toxicity, neurotoxicity, cardiotoxicity and hepatotoxicity toward human relevance.
Alzualde A; Behl M; Sipes NS; Hsieh JH; Alday A; Tice RR; Paules RS; Muriana A; Quevedo C
Neurotoxicol Teratol; 2018; 70():40-50. PubMed ID: 30312655
[TBL] [Abstract][Full Text] [Related]
13. Novel aspects of uptake patterns, metabolite formation and toxicological responses in Salmon exposed to the organophosphate esters-Tris(2-butoxyethyl)- and tris(2-chloroethyl) phosphate.
Arukwe A; Carteny CC; Eggen T; Möder M
Aquat Toxicol; 2018 Mar; 196():146-153. PubMed ID: 29407800
[TBL] [Abstract][Full Text] [Related]
14. [ORGANOPHOSPHORUS FLAME RETARDANTS - TOXICITY AND INFLUENCE ON HUMAN HEALTH].
Bruchajzer E; Frydrych B; Szymańska JA
Med Pr; 2015; 66(2):235-64. PubMed ID: 26294315
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro biological effects of the flame retardants tris(2,3-dibromopropyl) phosphate and tris(2-chlorethyl)orthophosphate.
Sala M; Gu ZG; Moens G; Chouroulinkov I
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1337-44. PubMed ID: 6891932
[TBL] [Abstract][Full Text] [Related]
16. Tris(2,3-dibromopropyl) phosphate.
IARC Monogr Eval Carcinog Risks Hum; 1999; 71 Pt 2(PT 2):905-21. PubMed ID: 10476477
[No Abstract] [Full Text] [Related]
17. Nephrotoxicity and hepatotoxicity of tris(2,3-dibromopropyl)phosphate in the rat.
Söderlund E; Dybing E; Nelson SD
Toxicol Appl Pharmacol; 1980 Nov; 56(2):171-81. PubMed ID: 7466817
[No Abstract] [Full Text] [Related]
18. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.
Gold MD; Blum A; Ames BN
Science; 1978 May; 200(4343):785-7. PubMed ID: 347576
[TBL] [Abstract][Full Text] [Related]
19. Tris(2,3-dibromopropyl) phosphate.
National Toxicology Program
Rep Carcinog; 2011; 12():428-9. PubMed ID: 21863116
[No Abstract] [Full Text] [Related]
20. Developmental circulatory failure caused by metabolites of organophosphorus flame retardants in zebrafish, Danio rerio.
Lee JS; Morita Y; Kawai YK; Covaci A; Kubota A
Chemosphere; 2020 May; 246():125738. PubMed ID: 31918085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
